脓毒症、感染或炎症性疾病ICU幸存者的三年死亡率:2007至2019年荷兰ICU患者个体匹配队列研究
该多中心队列研究纳入2007年1月1日至2019年1月1日期间荷兰78个ICU收治的成人ICU幸存者,按入ICU 24小时内APACHE IV入院诊断分为脓毒症、感染(非脓毒症)和炎症性疾病三组,各约1万例,并与健康保险理赔数据库链接获取3年死亡率。出院后3年死亡率脓毒症组32.7%、感染组33.6%、炎症性疾病组23.8%。调整后3年死亡HR:感染组对比脓毒症组1.00(95%CI 0.95-1.05),炎症性疾病组对比脓毒症组0.88(95%CI 0.83-0.94)。作者认为,因感染而需ICU入院本身即增加远期死亡风险,应加强脓毒症、感染及严重炎症性疾病幸存者的ICU后管理。
要点
- 脓毒症ICU出院幸存者3年死亡率为32.7%(N=10,000)。
- 非脓毒症感染ICU出院幸存者3年死亡率为33.6%(N=10,000),与脓毒症组调整后HR 1.00(95%CI 0.95-1.05)。
- 炎症性疾病ICU出院幸存者3年死亡率为23.8%(N=9997),较脓毒症组调整后HR 0.88(95%CI 0.83-0.94)。
- 脓毒症与感染患者约三分之一在出院后3年内死亡,比炎症性疾病患者高约10%。
- 作者认为,因感染而需ICU入院增加远期死亡风险,需加强脓毒症、感染和严重炎症性疾病幸存者的ICU后管理。
适用人群与场景
- 2007年1月1日至2019年1月1日期间荷兰78个ICU收治、出院时存活的成人ICU患者,按入ICU 24小时内APACHE IV入院诊断分为脓毒症、感染(非脓毒症)或炎症性疾病。
- 脓毒症定义为感染伴多器官衰竭;感染指感染但不满足脓毒症;炎症性疾病指非感染所致的炎症性疾病。
诊断标准与关键阈值
- 分组依据为入ICU 24小时内的APACHE IV入院诊断。
- 脓毒症:感染伴多器官衰竭;感染:感染但非脓毒症;炎症性疾病:非感染所致的炎症性疾病。
研究设计与关键结果
- 多中心队列研究,荷兰78个ICU,纳入2007年1月1日至2019年1月1日成人ICU幸存者,按APACHE IV入院诊断分为脓毒症(N=10,000)、感染(N=10,000)和炎症性疾病(N=9997)三组。
- 出院后3年死亡率:脓毒症组32.7%,感染组33.6%,炎症性疾病组23.8%。
- 对比脓毒症组,出院后3年内死亡的调整HR:感染组1.00(95%CI 0.95-1.05),炎症性疾病组0.88(95%CI 0.83-0.94)。
- 作者结论:脓毒症和非脓毒症感染患者出院后3年死亡风险均显著高于炎症性疾病患者;脓毒症与感染患者之间无差异,提示因感染而需ICU入院增加远期死亡风险。
证据类型、等级与局限
- 研究类型:多中心队列研究(荷兰78个ICU,NICE登记数据库与健康保险理赔数据库链接)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,研究结果强调需要更加关注脓毒症、感染和严重炎症性疾病幸存者的ICU后管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a frequent reason for ICU admission and a leading cause of death. Its incidence has been increasing over the past decades. While hospital mortality is decreasing, it is recognized that the sequelae of sepsis extend well beyond hospitalization and are associated with a high mortality rate that persists years after hospitalization. The aim of this study was to disentangle the relative contribution of sepsis (infection with multi-organ failure), of infection and of inflammation, as reasons for ICU admission to long-term survival. This was done as infection and inflammation are both cardinal features of sepsis. We assessed the 3-year mortality of ICU patients admitted with sepsis, with individually matched ICU patients with an infection but not sepsis, and with an inflammatory illness not caused by infection, discharged alive from hospital.
METHODS: A multicenter cohort study of adult ICU survivors admitted between January 1st 2007 and January 1st 2019, with sepsis, an infection or an inflammatory illness. Patients were classified within the first 24 h of ICU admission according to APACHE IV admission diagnoses. Dutch ICUs (n = 78) prospectively recorded demographic and clinical data of all admissions in the NICE registry. These data were linked to a health care insurance claims database to obtain 3-year mortality data. To better understand and distinct the sepsis cohort from the non-sepsis infection and inflammatory condition cohorts, we performed several sensitivity analyses with varying definitions of the infection and inflammatory illness cohort.
RESULTS: Three-year mortality after discharge was 32.7% in the sepsis (N = 10,000), 33.6% in the infectious (N = 10,000), and 23.8% in the inflammatory illness cohort (N = 9997). Compared with sepsis patients, the adjusted HR for death within 3 years after hospital discharge was 1.00 (95% CI 0.95-1.05) for patients with an infection and 0.88 (95% CI 0.83-0.94) for patients with an inflammatory illness.
CONCLUSIONS: Both sepsis and non-sepsis infection patients had a significantly increased hazard rate of death in the 3 years after hospital discharge compared with patients with an inflammatory illness. Among sepsis and infection patients, one third died in the next 3 years, approximately 10% more than patients with an inflammatory illness. The fact that we did not find a difference between patients with sepsis or an infection suggests that the necessity for an ICU admission with an infection increases the risk of long-term mortality. This result emphasizes the need for greater attention to the post-ICU management of sepsis, infection, and severe inflammatory illness survivors.
参考来源
- Arbous SM, Termorshuizen F, Brinkman S, et al. Three-year mortality of ICU survivors with sepsis, an infection or an inflammatory illness: an individually matched cohort study of ICU patients in the Netherlands from 2007 to 2019. Crit Care. 2024. PMID: 39563453. doi:10.1186/s13054-024-05165-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。